Joint pain severity was significantly reduced in Instaflex compared to placebo ( 8-week WOMAC , 37 % versus 16 % , respectively , interaction effect P = 0.025 ) , with group differences using the 12-VS emerging by week 4 of the study ( interaction effect , P = 0.0125 ) .